Phase Analysis and Obstructive CAD on Rubidium PET
NCT01840696 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2014-06-02
Summary
Rubidium myocardial perfusion PET is an imaging test used to diagnose patients with abnormal blood flow to the heart secondary to narrowing of the heart vessels.
Phase analysis is a computer method that is applied after the PET test is done. It is used to determine when a region of the heart contracts relative to other heart regions in the heart beating cycle. Initial data suggest that regions of the heart with abnormal blood flow change the pattern of contraction from rest to stress conditions. That is, regions of the heart with abnormal blood supply become dyssynchronous when compared to the normal regions of the heart.
This study will investigate whether phase analysis may aid the visual interpretation of rubidium myocardial perfusion PET studies by determining the areas of the heart that are not beating in synchrony with the normal heart regions. This information will be used as a proxy for poor blood supply. The gold standard will be coronary angiography by which the percent narrowing of the heart vessels is assessed.
Conditions
Interventions
- DRUG
-
Regadenoson
Vasodilator stress testing
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Fabio Esteves, MD · Emory University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
NCT01917136 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
NCT01446094 ·Status: UNKNOWN ·Phase: PHASE4
-
Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 2
NCT03481712 ·Status: COMPLETED
-
CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects
NCT01826773 ·Status: COMPLETED ·Phase: PHASE2
-
Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy
NCT03415789 ·Status: COMPLETED
-
Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT06348524 ·Status: TERMINATED ·Phase: PHASE3
-
Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)
NCT04795856 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
NCT01681524 ·Status: WITHDRAWN ·Phase: PHASE3
-
Gadofosveset Trisodium for Heart Imaging Studies
NCT01853592 ·Status: COMPLETED
-
The "MyoThrombus" Study
NCT04829825 ·Status: COMPLETED
-
PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR
NCT05349084 ·Status: COMPLETED ·Phase: NA
-
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
NCT07083011 ·Status: RECRUITING ·Phase: PHASE2
-
Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
NCT01779869 ·Status: COMPLETED ·Phase: PHASE4
-
Myocardial Perfusion Imaging Galmydar Rest/Stress
NCT05625490 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
NCT00763035 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT04600115 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
NCT02740699 ·Status: TERMINATED ·Phase: PHASE4
-
Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies
NCT01949844 ·Status: COMPLETED ·Phase: NA
-
Understanding the Mechanisms of Diastolic Dysfunction
NCT03340233 ·Status: WITHDRAWN ·Phase: NA
-
PET/CT Study in the Diagnosis of Coronary Plaque
NCT00850473 ·Status: TERMINATED ·Phase: NA
-
Myocardial Perfusion Imaging by Combined 15O-H2O PET and MR
NCT04940247 ·Status: COMPLETED
-
Cardiac Fibroblast Activation Detected by 68Ga-FAPI PET/MR
NCT04723953 ·Status: COMPLETED ·Phase: NA
-
Right Ventricular Damage in Cardiovascular Magnetic Resonance
NCT01359306 ·Status: COMPLETED
-
Determinants of the Progression and Outcome of Mitral Regurgitation
NCT01835054 ·Status: UNKNOWN
-
Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status
NCT04475094 ·Status: UNKNOWN